Objective: The majority of late endovascular aneurysm repair (EVAR) complications can be easily managed by endovascular means. Nevertheless, a late open conversion (LOC) is sometimes required. The aim of the study was to report the outcomes and technical aspects of a multicenter experience of LOC after EVAR performed electively.
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Objective: Aortic endograft treatment with fenestrated or branched devices requires a connection between the aortic graft and the visceral vessel (VV); however, data on the perioperative and long-term fate of the VV are still scarce. The aim of our study was to evaluate VV loss (VVL) according to the type of revascularization performed (fenestrations vs branched) and adjunctive visceral procedures (AVPs) necessary.
Methods: From 2012 to 2017, all fenestrated or branched endovascular repairs of juxtarenal aortic aneurysms (JAAAs), pararenal aortic aneurysms (PAAAs), and thoracoabdominal aortic aneurysms (TAAAs) were considered. Perioperative VVL, AVPs, and graft configuration were considered and evaluated during the follow-up.
Results: There were 523 VVs considered, 26% (140) in JAAAs, 32% (165) in PAAAs, and 42% (218) in TAAAs. Branches were used for 114 (52%) vessels in TAAAs, 8 (5%) . At 5 years, VVL was 2% 6 1%; fenestrations showed significantly higher VVL-free survival compared with branches (100% vs 87% 6 6%; P ¼ .04), and this was confirmed selectively for TAAAs (100% vs 87% 6 6%; P ¼ .04). AVPs did not affect the long-term visceral patency.
Conclusions: Early and late VVL is infrequent in complex aortic procedures but seems to occur more frequently in branches compared with fenestrations, specifically in renal arteries. AVPs are often required to correct artery kinking, but this does not affect long-term patency. Objective: The objective of this study was to evaluate the patency of the unstented superior mesenteric artery (SMA) after fenestrated EVAR (F-EVAR) using duplex ultrasound (DUS) and computed tomography angiography (CTA).
Methods: Patients with SMA fenestrations or crossing struts were identified from a database of patients who underwent F-EVAR at our institution between 2011 and 2017 as part of an investigational device exemption clinical trial (NCT01538056). Mesenteric DUS and CTA data were obtained at baseline and at 30 days, 6 months, and annually out to 5 years. The DUS parameter of SMA peak systolic velocity (PSV) of 275 cm/s was used to detect 70% SMA stenosis. CTA was used to evaluate the patency of the SMA when DUS PSV was elevated or if DUS was not performed.
Results: There were 107 patients who underwent endograft placement involving the SMA in association with F-EVAR. There were 87 SMA fenestrations and 20 bare-metal struts crossing the SMA; 79 patients had baseline and at least 30-day follow-up DUS SMA PSV measurements (64 fenestrations, 15 struts). Mean follow-up was 18.6 months (range, 30 days-5 years). SMA PSVs are listed in the Table. Mean PSVs remained well below the threshold velocity of 275 cm/s for native atherosclerotic 70% SMA stenosis. Nine patients had at least one SMA PSV >275 cm/s during follow-up. All were observed and showed no subsequent clinical sequelae. All patients had at least 30-day follow-up with CTA, and all 
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June 2018 had widely patent SMAs at last follow-up. Mean total seal zone length was 41.4 mm. There was a single secondary intervention for asymptomatic SMA stenosis requiring stent placement 1 year after F-EVAR. There were no Type IA endoleaks and no endoleaks related to SMA fenestrations. Five patients of the entire cohort (4.7%) required SMA stenting at the index procedure. Three of these patients had prior EVAR (n ¼2) or open repair (n ¼ 1), One patient had a pre-existing critical SMA stenosis and underwent planned SMA stenting, and in one patient, the graft was deployed imprecisely and low, and the SMA was successfully stented from a brachial approach.
Conclusions:
The unstented SMA in association with F-EVAR remains widely patent in the presence of fenestrations or struts and is not associated with endoleaks. The need for adjunctive SMA stenting may be related to prior aortic intervention and case complexity. Follow-up DUS and CTA surveillance confirms that SMA patency remains in the normal or <70% stenosis range after F-EVAR regardless of whether it is encompassed by a large fenestration or crossing struts. Objective: Although endovascular aneurysm repair (EVAR) has minimal perioperative morbidity and mortality, it is still associated with increased radiation exposure and contrast material use. Three-dimensional (3D) fusion computed tomography (CT) technology has the potential to revolutionize endovascular management of aneurysms by mitigating radiation exposure. Currently available 3D fusion devices use hardware-based (ie, operating table) tracking to position the overlay on the fluoroscopic image. This can be labor-intensive and lead to inaccurate overlay. Recently, our institution implemented a novel cloud-based 3D fusion system, which has been shown in prior studies to be highly accurate. This system uses the patient's vertebral anatomy rather than the operating table to register and produce the overlay, and it can be used with any imaging system, including C arm. The purpose of this study was to investigate the impact of this new 3D fusion system on EVAR.
Methods: Our institutional database was reviewed to identify patients who underwent elective EVAR or fenestrated EVAR. Patients treated using 3D fusion CT were compared with patients treated in the immediate 6 months before the implementation of 3D fusion CT at our institution. Primary end points included the patient's radiation exposure, contrast material use, fluoroscopy time, and procedure time.
Results: A total of 108 patients (67 before vs 41 after 3D fusion CT implementation) underwent EVAR or fenestrated EVAR from October 2016 through December 2017. There was a significant decrease in radiation exposure (3006 vs 2112 mGy; P ¼ .015), fluoroscopy time (36.8 vs 27.9 minutes; P ¼ .022), and procedure time (163.7 vs 127.5 minutes; P ¼ .007) with cloud-based digitally registered intraoperative 3D fusion CT. There was no difference in contrast material use (78 vs 73.9 mL; P ¼ .183) between the two groups (Table) .
Conclusions: The results of this study demonstrate that the use of intraoperative image-based 3D fusion CT during EVAR decreases radiation exposure, fluoroscopy time, and procedure time. This novel technology has the potential to improve clinical outcomes, to reduce costs, and to broaden the application of 3D fusion imaging.
Author Disclosures: M. Cox: Nothing to disclose; B. Gilmore: Nothing to disclose; C. Long: Nothing to disclose; R. McCann: Nothing to disclose; U. Nag: Nothing to disclose; C. Shortell: Nothing to disclose; K. W. Southerland: Nothing to disclose; M. Turner: Nothing to disclose IF10. Objective: In infrainguinal bypass for arteriosclerosis obliterans, the association between ambulatory status (AS) and graft performance is not well studied. The aim of this study was to elucidate the relationship between the postoperative AS and the time course of graft performance.
Methods: From January 2013 to June 2017, there were 179 bypass grafts distal to the popliteal artery with vein grafts enrolled; 35 grafts that were followed-up <6 months were excluded, and 144 grafts were finally enrolled. They were classified into two groups based on the postoperative AS: ambulation group (AG; n ¼ 91), including consistently ambulatory patients and patients who regained ambulation after rehabilitation; and non-AG (NAG; N ¼ 53), including bedridden status and patients with wheelchair or walker with limited physical activity. Graft flow (GF) and graft caliber (GC) were measured by duplex ultrasound, which was performed 1 month after surgery, every 3 months within 2 years, and every 6 months thereafter. GF ratio (GFr) and GC ratio (GCr) were calculated, dividing each measured value by the initial value within 1 month after surgery, and then the GFr and GCr change over time in relation to postoperative AS was analyzed, using a mixed model approach with a univariate split-plot analysis of variance and multivariate analysis of variance.
Results: Time after surgery and AS over time had significant influence on both GFr change (F ¼ 7.79 and 5.01, respectively; P < .0001) and GCr change (F ¼ 3.38 and 3.40, respectively; P < .0001). The trend of GFr and GCr change over time differed significantly between AG and NAG. In regard to GFr, AG maintained the same level of initial value throughout the time course (1 year: 0.93; P ¼ 1.0), whereas NAG showed marked decrease immediately after surgery and subsequent gradual decrease (3 months: 0.73 [P ¼ .0009]; 1 year: 0.58 [P < .0001]). GCr showed the same trend: AG maintained the initial value over time, whereas NAG showed gradual decrease (3 months: 0.94 [P ¼ .022]; 1 year: 0.91 [P ¼ .0005]). In regard to patency, there was no significant difference in primary patency (1 year: 63.8% in AG, 57.8% in NAG; P ¼ .30), but secondary patency was significantly better in AG (1 year: 96.6% in AG, 88.2% in NAG; P ¼ .012).
Conclusions: Postoperative ambulation maintained graft performance including flow and caliber, whereas non-AS showed gradual impairment of graft performance. Ambulatory function may have a protective effect on graft function and lead to subsequent good clinical outcomes.
Author Disclosures: N. Azuma: Nothing to disclose; S. Kikuchi: Nothing to disclose; A. Koya: Nothing to disclose; K. Miyake: Nothing to disclose; Y. Sawa: Nothing to disclose; D. Uchida: Nothing to disclose. 
